Pharmacokinetics and Pharmacodynamics of diclofenac in the presence and absence of glibenclamide in the rat
PURPOSE. There are evidences that glibenclamide, a sulfonylurea antidiabetic agent, reduces the analgesic action of non-steroidal anti-inflammatory drugs (NSAIDs), opioids and neuromodulators in animal models. The purpose of this work was to examine in the rat if such interaction involves pharmacoki...
Saved in:
Main Authors: | María R León-Reyes (Author), Gilberto Castañeda-Hernández (Author), Mario I Ortiz (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2016-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacokinetic of Diclofenac in the Presence and Absence of Glibenclamide in the Rat
by: María R. León-Reyes, et al.
Published: (2009) -
Glibenclamide population pharmacokinetic/pharmacodynamic modeling in South African type 2 diabetic subjects
by: Rambiritch V, et al.
Published: (2016) -
Assessment of glibenclamide pharmacokinetics in poloxamer 407-induced hyperlipidemic rats
by: Yousef A. Bin Jardan, et al.
Published: (2021) -
Changes in the pharmacokinetics of glibenclamide in rats with streptozotocin-induced diabetes mellitus
by: Yuqing Li, et al.
Published: (2012) -
Formulation of Glibenclamide proniosomes for oral administration: Pharmaceutical and pharmacodynamics evaluation
by: Doaa Alshora, et al.
Published: (2023)